Aikorkem Mustafayeva

Dr. Aikorkem Mustafayeva

Population genetics laboratory, Institution of Genetics and Physiology, Almaty, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2026 in Life
Verified
Journal Article
Open access
PDF file
ZZZhassulan Zhaniyazov
Zhassulan Zhaniyazov
AKAkmaral Kulatayeva
Akmaral Kulatayeva
NANazym Altynova
Nazym Altynova
ZZZhuldyz Zhaksybay
Zhuldyz Zhaksybay
ABAssel Berikkyzy Baidullayeva
Assel Berikkyzy Baidullayeva
Leyla Bulatovna DjansugurovaLeyla Bulatovna Djansugurova
Leyla Bulatovna Djansugurova
Kazakh populations occupy an important position within the genetic landscape of Central Asia and Inner Eurasia, yet compact ancestry-informative marker panels evaluated for Kazakh-related ancestry remain limited. We analyzed genome-wide single-nucleotide polymorphism data from 624 Kazakh individuals together with data from external reference populations. After harmonization, the discovery dataset comprised 1607 individuals from 41 population groups and 80,766 shared autosomal variants. Candidate ancestry-informative markers were ranked using allele-frequency differentiation and informativeness for assignment, followed by linkage disequilibrium filtering. The final panel comprised 385 markers. Because marker availability differed across external datasets, transferability assessment in two independent Kazakh cohorts (n = 224 and n = 132) was performed using the 341-marker subset shared across the internal dataset and both external cohorts. Principal component analysis showed that both external Kazakh cohorts overlapped substantially with the internal Kazakh cluster. In nearest-centroid analysis, 94.6% of internal Kazakh individuals and 92.0% and 91.7% of individuals from the two external Kazakh cohorts, respectively, were assigned as Kazakh-related. Among non-Kazakh reference individuals used in the discovery framework, 4.1% were assigned as Kazakh-related; this internal, selection-informed estimate was mainly driven by genetically close Central Asian and Inner Eurasian populations. These findings support the transferability of the shared marker subset across independent Kazakh datasets, while also showing limited discrimination between Kazakhs and several closely related neighboring populations.

1 September 2026 in Biology
Verified
Journal Article
Open access
PDF file
ZZZhassulan Zhaniyazov
Zhassulan Zhaniyazov
AKAkmaral Kulatayeva
Akmaral Kulatayeva
Aikorkem MustafayevaAikorkem Mustafayeva
Aikorkem Mustafayeva
AAAssel Aulbekova
Assel Aulbekova
NANazym Altynova
Nazym Altynova
Leyla Bulatovna DjansugurovaLeyla Bulatovna Djansugurova
Leyla Bulatovna Djansugurova
Central Asian populations remain underrepresented in pharmacogenomic research, limiting the availability of population-specific data for genotype-informed prescribing and precision medicine. This study analyzed clinically relevant pharmacogenomic variant frequencies in Kazakh, Russian, and Uzbek population groups residing in Kazakhstan using genome-wide genotype data from 1301 individuals: Kazakh (n = 1111), Russian (n = 156), and Uzbek (n = 34). ClinPGx, a PharmGKB-based clinical annotation framework that prioritizes variant–drug associations according to levels of evidence, was used to select variants with evidence levels 1A, 1B, and 2A. In total, 112 directly genotyped variants were retained for population-specific allele and genotype frequency analysis. All 112 variants were queried against the gnomAD v4.1 genome and exome reference datasets. Of these, matching allele-frequency data for the predefined reported allele were available in at least one of the two gnomAD datasets for 103 variants, whereas for 9 variants the VEP-based query did not return a matching gnomAD frequency for that allele. Frequencies were reported for the same predefined reported allele across all groups, and differences between the study groups were assessed using 95% confidence intervals, Fisher’s exact tests, and false discovery rate correction. Genotype counts and the proportions of individuals carrying at least one copy of the reported allele were also summarized for all selected variants. Several pharmacogenomic variants showed population-specific frequency patterns, including NUDT15 rs116855232, SLCO1B1 rs4149056, VKORC1 rs9934438, and UGT1A1 rs10929302. Comparison with gnomAD showed that the observed frequencies were variant-specific and could not be consistently approximated by a single broad genetic ancestry group. Reference-based population structure analysis provided additional ancestry context and supported separate reporting by population group. The study did not evaluate clinical outcomes or make individual prescribing recommendations, and the small Uzbek sample size limits the precision of frequency estimates for this group, particularly for rare variants. Overall, this study provides a clinically prioritized pharmacogenomic frequency resource for underrepresented population groups in Kazakhstan and supports broader Central Asian representation in pharmacogenomic implementation research.

28 July 2026 in Biology
Verified
Journal Article
Open access
PDF file
ZZZhassulan Zhaniyazov
Zhassulan Zhaniyazov
AKAkmaral Kulatayeva
Akmaral Kulatayeva
Aikorkem MustafayevaAikorkem Mustafayeva
Aikorkem Mustafayeva
BABakytzhan Anapiyayev
Bakytzhan Anapiyayev
KIKonirsha Iskakova
Konirsha Iskakova
Leyla Bulatovna DjansugurovaLeyla Bulatovna Djansugurova
Leyla Bulatovna Djansugurova
Turkmen populations remain underrepresented in genome-wide reference datasets, limiting comparative analyses of genetic diversity in Central Asia. This study provides an initial regional genome-wide characterization of self-identified Turkmen students who were studying in Kazakhstan at the time of sample collection and who reported the Dashoguz Region, Turkmenistan, as their place of birth in the questionnaire. Approximately 650,000 markers were genotyped in 25 participants, of whom 23 unrelated individuals were retained after genotype quality control and relatedness filtering. Population structure was evaluated with 600 present-day Eurasian reference individuals using principal component analysis, ADMIXTURE v1.3.0, and pairwise Weir–Cockerham FST estimates based on 17,471 linkage-disequilibrium-pruned autosomal SNPs. Runs of homozygosity, Y-chromosome haplogroups, and mitochondrial DNA haplogroups were also examined. The analyzed cohort was positioned within the Central Asian genetic landscape and showed the lowest pairwise differentiation from Uzbek, Tajik, and AADR Turkmen reference groups. Runs-of-homozygosity analysis showed mostly low-to-moderate individual burdens, although one individual had elevated long-segment homozygosity; sensitivity analyses indicated that the main autosomal results were not driven by this individual. Paternal and maternal haplogroup assignments revealed diverse uniparental lineages. These data provide a regional genome-wide resource for future comparative studies of Central Asian genetic diversity and have been deposited in the European Variation Archive.

6 October 2026 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Closed access
PDF file
TKT.N. Kereyev
T.N. Kereyev
Aikorkem MustafayevaAikorkem Mustafayeva
Aikorkem Mustafayeva
ZZZhassulan Zhaniyazov
Zhassulan Zhaniyazov
NANazym Altynova
Nazym Altynova
GZGulnur Zhunussova
Gulnur Zhunussova
SMSaltanbek Mukhambetzhanov
Saltanbek Mukhambetzhanov
Based on the analysis of global experience and our own preliminary studies aimed at identifying associations between athletic performance potential and individual genotypes across 97 SNP polymorphisms (75 candidate genes), interpretations of possible genotype variants for an athlete’s genetic passport were developed. A software program and several auxiliary scripts were created using the RStudio development environment and the Python programming language. The developed tools efficiently create and update databases containing the required genetic information, reducing the time needed to develop a genetic passport while minimizing the risk of errors. These tools significantly improved the efficiency of storing, sorting, and processing primary data obtained from genome-wide SNP microarray genotyping. The reduction of human involvement in the repetitive process of collecting and comparing tables minimized the risk of errors and facilitated the analysis of genotyping data. Automation of primary and secondary processing of genome-wide SNP microarray genotyping data, genotype interpretation, database updating, and generation of completed genetic passport reduced data processing time from several months to 20-30 minutes.

14 November 2025 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Open access
PDF file
LDLeyla Djansugurova
Leyla Djansugurova
STSaida Tokmurzina
Saida Tokmurzina
Aikorkem MustafayevaAikorkem Mustafayeva
Aikorkem Mustafayeva
MSMaxim Shtilkind
Maxim Shtilkind
NANazym Altynova
Nazym Altynova
ACAinash Childebayeva
Ainash Childebayeva
Background: Natural selection in Human favored the development of cognitive functions such as memory, attention, planning, problem solving, since these skills increased the chances of survival and reproduction. At the same time, current human lifespan led to increasing the cases of neurodegenerative diseases. Most of all manifest themselves in old age, and causal mutations pass for generations influencing on natural selection and genetic load. GWAS studies of modern population made possible to study the population of past eras. Our aim was to evaluate selective signals of cognitive functions and neurodegenerative diseases in ancient and modern populations of the Central Eurasian region. Materials and methods: We downloaded from the AADR the 1240K-captured genome data of 470 ancient individuals from Central Eurasia. For modern population analysis, we used genome data of 2,500 individuals from 1000G. Whole-genome data of 898 modern Kazakh individuals were taken from our resource. The SmartPCAv.16,000, ADMIXTUREv1.3.0, and pcadaptv4.3.5 packages were used to determine the population structure and assess the selection signals. For annotation and interpretation of SNP selection candidates we’ve used BioMart3.22 package, Gowinda1.12, Revigov1.8.1. Results: After quality control and filtration of ancient genome data (total genotyping rate was 0.721805, 416,508 SNPs), ancient DNAs were divided to millennium time periods: 12000 -5000 (21 samples), 5000-4000 (58), 4000-3000 (139), 3000-2000 (153), 2000-500 (99) years ago. The modern Kazakh DNA genotyped data (654,027 SNPs) were imputed, and subset SNPs from 1,240k compiled 863k. The analysis of SNP candidates for selection was done in separate subgroups. The analysis applied a q-value cutoff (q<0.05) to minimize false positive results. Significantly, 413 SNP selection candidates were revealed in total. After interpretation and annotation SNP variants, the phenotypes associated with cognitive functions were selected. In total, selection signals analysis revealed 91 SNPs of 42 genes, that could be involved in selection of cognitive features in populations through time. Conclusion: Such cognitive functions as stress sensitivity, memory, attention, logic, chronotype were predominantly selectable phenotypes during Bronze and Iron Ages. The characteristics of recent times have become an increase in susceptibility to diseases such as Alzheimer's disease, Parkinson's disease, autism, epilepsy, bipolar disorder, depression, insomnia, and neuroticism.